This protocol is judged by an institutional evaluation board, an independent team that critiques any scientific trials involving individuals. If a study requires a Plan I drug, after the board approves the protocol as moral, the researchers have to submit an application for an investigational new drug (IND) range through the FDA.Some researchers an